Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Property, Plant & Equipment (Net) (2013 - 2026)

Analysis

Rezolute (RZLT) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Rezolute 477.02 Mn 477.02 Mn - 49,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 49,000.00
Dec 31, 2025 57,000.00
Sep 30, 2025 64,000.00
Jun 30, 2025 72,000.00
Mar 31, 2025 80,000.00
Dec 31, 2024 87,000.00
Sep 30, 2024 95,000.00
Jun 30, 2024 103,000.00
Mar 31, 2024 110,000.00
Dec 31, 2023 119,000.00
Sep 30, 2023 129,000.00
Jun 30, 2023 139,000.00
Mar 31, 2023 149,000.00
Dec 31, 2022 160,000.00
Sep 30, 2022 83,000.00
Jun 30, 2022 16,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 26,000.00
Jun 30, 2021 29,000.00